References
- GoASMozaffarianDRogerVLAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics – 2014 update: a report from the American Heart AssociationCirculation20141293e28e29224352519
- KhanMDhammuTSMatsudaFPromoting endothelial function by S-nitrosoglutathione through the HIF-1α/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in ratsDrug Des Devel Ther2015922332247
- DonnanGAFisherMMacleodMDavisSMStrokeLancet20083711612162318468545
- KraftPSchwarzTMeijersJCMStollGKleinschnitzCThrombin-activatable fibrinolysis inhibitor (TAFI) deficient mice are susceptible to intracerebral thrombosis and ischemic strokePLoS One20105e1165820657835
- MackmanNTriggers, Targets and treatments for thrombosisNature200845191491818288180
- ZhangYWangLLiJWangXL2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemiaJ Pharmacol Exp Ther200631797397916527903
- GinsbergMDNeuroprotection for ischemic stroke: past, present and futureNeuropharmacology20085536338918308347
- PandyaRSMaoLZhouHCentral nervous system agents for ischemic stroke: neuroprotection mechanismsCent Nerv Syst Agents Med Chem201111819721521165
- BouckaertMLemmensRThijsVReducing prehospital delay in acute strokeNat Rev Neurol2009547748319668246
- van den BergJSde JongGWhy ischemic stroke patients do not receive thrombolytic treatment: results from a general hospitalActa Neurol Scand200912015716019719807
- BrowningJDHortonJDMolecular mediators of hepatic steatosis and liver injuryJ Clin Invest200411414715215254578
- TuttolomondoAPecoraroRPintoAStudies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to dateDrug Des Devel Ther2014822212239
- HarukuniIBhardwajAMechanisms of brain injury after global cerebral ischemiaNeurol Clin20062412116443127
- WangTGuJWuPFProtection by tetrahydroxystilbene gluco-side against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generationFree Radic Biol Med20094722924019272442
- Candelario-JalilEInjury and repair mechanisms in ischemic stroke: considerations for the development of novel neuro-therapeuticsCurr Opin Invesigt Drugs200910644654
- MurakamiKKondoTKawaseMMitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiencyJ Neurosci1998182052139412501
- SuzukiKAnti-oxidants for therapeutic use: why are only a few drugs in clinical use?Adv Drug Deliv Rev20096128728919306902
- LiuCLLiaoSJZengJSDL-3-n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSPJ Neurol Sci200726010611317553527
- PengYZengXFengYWangXAntiplatelet and antithrombotic activity of L-3-n-butyphthalide in ratsJ Cardiovasc Pharmacol20044387615167282
- LiLZhangBTaoYDL-3-n-butylphthalide protects endothelial cells against oxidative/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitroBrain Res200912909110119616517
- WangXLLiYZhaoQDesign, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agentsOrg Biomol Chem201195670568121706121
- ZhaoCHeZCuiSZhangRDetermination of 3-n-butylphthalide in rabbit plasma by HPLC with fluorescence detection and its application in pharmacokinetic studyBiomed Chromatogr20031739139513680850
- XuBZhaoZButylphthalide injection, an innovative drug originated in China for the treatment of ischemic strokeChin J New Drugs20112011
- ZhaoCStudies on Pharmacokinetics of 3-n-Butylphthalide in Rats and Rabbits and the Transport Mechanism in Brain [doctorate thesis]ShenyangShenyang Pharmaceutical University2003
- LuRThe Comparative Study on Pharmacokinetics of R- and S-isomers of NBP in Beagle Dogs [master thesis]TianjinTianjin Medical University2006
- ZhuYTanSObservation of DL-3-n-butylphthalide combined edaro-vone treating 36 patients with progressive cerebral infarctionChin J Pract Nerv Dis2010131012
- BelliottiTRBrinkWAKestenSRIsoindolinone enantiomers having affinity for the dopamine D4 receptorBioorg Med Chem Lett19988149915029873377
- DrutuIHurleyDJBandarageUKinventorVertex Pharmaceuticals Incorporated, USA., assigneeSpiropiperidine derivatives as modulators of muscarinic receptors and their preparation, pharmaceutical composition and use for treatment of muscarinic receptor-mediated diseasesUnited States patent US 2006027065320061130
- GreigNHHollowayHBrossiAinventorThe Secretary of the Department of Health and Human Services USA., assigneePreparation of thalidomide analogs as modulators of TNF-α activity and angiogen-esisUnited States patent US 200602117282006921
- CarryJCMignaniSBigotARonanBKleemannHWHofmeisterAinventorAventis Pharma Sa, Fr, assigneePreparation of isoindolones as NHE (sodium/hydrogen exchanger) inhibitors, and their pharmaceutical compositions used as cytoprotective agentsUnited States patent US 200400489162004311
- TweedieDGiordanoTYuQSTNF-α synthesis inhibitors on the 3-phthalimidoglutarimide backbone as therapeutic candidates for neuro-degenerative diseases7th International Conference on Alzheimer’s and Parkinson’s DiseaseMarch 9–13 2005Sorrento, ItalyBolognaMonduzzi Editore20057786
- HagmannWKLinLSShahSKinventorMerck & Co Inc., USA., assigneePreparation of substituted amides as antagonists and/or inverse agonists of the cannabinoid-1 receptor for therapyUnited States patent US 200400588202004325
- SheridanJMHealJRHamiltonWDOPikeIinventorElectrophoret-ics Limited, UK., assigneeCasein kinase 1δ inhibitors for the treatment of neurodegenerative disordersUnited States patent US 201400185402014116
- AmbergWLangeUOchseMinventorAbbVie Inc., USAAbbVie Deutschland GmbH & Co. KG., assigneePreparation of isoindoline derivatives and their use in therapyUnited States patent US 201302108802013815
- BornGVRCrossMJThe aggregation of blood plateletsPhysiology1963168178
- BertelliAGiovanniniLGalmozziGBertelliAAProtective role of pro-pionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageeninDrugs Exp Clin Res1993197118223141
- LongaEZWeinsteinPRCarlsonSReversible middle cerebral artery occlusion without craniectomy in ratsStroke19892084912643202
- AshwalSToneBTianHRColeDJPearceWJCore and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusionStroke199829103710469596255
- RuanYPChenMDHeMZZhouXHuangPQA practical two-step synthesis of 3-alkyl-2,3-dihydro-1H-isoindolin-1-onesSynth Commun200434853861
- YeJQZhaiLLZhangSHDL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterasePlatelets201531925734213
- MaFFGYQHLHXJCJBAntiplatelet activity of 3-butyl-6-bromo-1(3H)-isobenzofuranone on rat platelet aggregationJ Thromb Thrombolysis201233647322057435
- ZhaoWHLuoCWangJ3-N-butylphthalide improves neuronal morphology after chronic cerebral ischemiaNeural Regen Res2014971972625206879
- ZhaoQZhangCWangXLChenLJiHZhangYH(S)-ZJM-289, a nitric oxide-releasing derivative of 3-n-butylph-thalide, protects against ischemic neuronal injury by attenuating mitochondrial dysfunction and associated cell deathNeurochem Int20126013414422142531
- HalliwellBRole of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatmentDrugs Aging20011868571611599635
- MoosmannBBehlCAntioxidants as treatment for neurodegenerative disordersExpert Opin Investig Drugs20021114071435
- IadecolaCZhangFYCaseyRClarkHBRossMEInducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemiaStroke199627137313808711805
- TalalayPDinkova-KostovaATHoltzclawWDImportance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesisAdv Enzyme Regul2003412113412791387
- SkutellaTLezoualc’hFPostAWidmannMNewtonCJHolsboerFNeuroprotection against oxidative stress by estrogens: structure-activity relationshipMol Pharmacol1997515355419106616
- DarguschRSchubertDSpecificity of resistance to oxidative stressJ Neurochem2002811394140012068086
- MoosmannBBehlCThe antioxidant neuroprotective effects of estro-gens and phenolic compounds are independent from their estrogenic propertiesProc Natl Acad Sci U S A1999968867887210430862
- SagaraYHendlerSKhoh-ReiterSPropofol hemisuccinate protects neuronal cells from oxidative injuryJ Neurochem1999732524253010582614
- TanSSomiaNMaherPSchubertDRegulation of antioxidant metabolism by translation initiation factor 2alphaJ Cell Biol2001152997100611238455
- DirnaglULindauerUThemAGlobal cerebral ischemia in the rat: online monitoring of oxygen free radical production using chemiluminescence in vivoJ Cereb Blood Flow Metab1995159299407593353
- LancelotECallebertJRevaudMLBouluRGPlotkineMDetection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damageNeurosci Lett199519785888552286
- MalinskiTBaileyFZhangZGChoppMNitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusionJ Cereb Blood Flow Metab1993133553588478395